These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

292 related items for PubMed ID: 10080622

  • 21. Fifteen-year secondary leukaemia risk observed in 761 patients with Hodgkin's disease prospectively treated by MOPP or ABVD chemotherapy plus high-dose irradiation.
    Delwail V, Jais JP, Colonna P, Andrieu JM.
    Br J Haematol; 2002 Jul; 118(1):189-94. PubMed ID: 12100147
    [Abstract] [Full Text] [Related]

  • 22. MOPP/ABVD chemotherapy for advanced Hodgkin's disease.
    Glick JH, Tsiatis A.
    Ann Intern Med; 1986 Jun; 104(6):876-8. PubMed ID: 2422998
    [No Abstract] [Full Text] [Related]

  • 23. Treatment of Hodgkin's disease in children with alternating mechlorethamine, vincristine, procarbazine, and prednisone (MOPP) and adriamycin, bleomycin, vinblastine, and dacarbazine (ABVD) courses without radiotherapy.
    van den Berg H, Stuve W, Behrendt H.
    Med Pediatr Oncol; 1997 Jul; 29(1):23-7. PubMed ID: 9142201
    [Abstract] [Full Text] [Related]

  • 24. MOPP, ABVD, or both to treat Hodgkin's disease.
    Martino R, Nomdedeu J, Brunet S.
    N Engl J Med; 1993 Apr 08; 328(14):1045; author reply 1045-6. PubMed ID: 7680766
    [No Abstract] [Full Text] [Related]

  • 25. Hodgkin's disease: the Milan Cancer Institute experience with MOPP and ABVD.
    Bonadonna G, Valagussa P, Santoro A, Viviani S, Bonfante V, Banfi A.
    Recent Results Cancer Res; 1989 Apr 08; 117():169-74. PubMed ID: 2481328
    [Abstract] [Full Text] [Related]

  • 26.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 27.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 28.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 29.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 30.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 31. Combined modality therapy for advanced Hodgkin's disease: 15-year follow-up data.
    Prosnitz LR, Farber LR, Kapp DS, Scott J, Bertino JR, Fischer JJ, Cadman EC.
    J Clin Oncol; 1988 Apr 08; 6(4):603-12. PubMed ID: 2451712
    [Abstract] [Full Text] [Related]

  • 32. High-dose chemotherapy with autologous bone marrow transplantation in 50 advanced resistant Hodgkin's disease patients: an Italian study group report.
    Carella AM, Congiu AM, Gaozza E, Mazza P, Ricci P, Visani G, Meloni G, Cimino G, Mangoni L, Coser P.
    J Clin Oncol; 1988 Sep 08; 6(9):1411-6. PubMed ID: 2458439
    [Abstract] [Full Text] [Related]

  • 33.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 34. Chemotherapy of Hodgkin's disease.
    Carde P.
    Nouv Rev Fr Hematol (1978); 1990 Sep 08; 32(2):169-73. PubMed ID: 1696000
    [Abstract] [Full Text] [Related]

  • 35.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 36. The case against the routine use of radiation therapy in advanced-stage Hodgkin's disease.
    Longo DL.
    Cancer Invest; 1996 Sep 08; 14(4):353-60. PubMed ID: 8689431
    [No Abstract] [Full Text] [Related]

  • 37.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 38.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 39.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 40.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 15.